US conditions sees CRH fall continue
CRH continued its downward trend with stock falling back to €15.80 as difficult trading conditions in the US continue to bite.
Elan saw its share price fall 27c to €4.30 from €4.57 after announcing yesterday that it planned to sell €85m ($100m) worth of products and assets to aaiPharma Inc.





